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BRIEF RESEARCH REPORTSSometimes an ounce of extracorporeal membrane oxygenation
prevention is worth a pound of extracorporeal membrane
oxygenation curePankaj Saxena, FRACS, PhD,a Randall Flick, MD,b and Kevin L. Greason, MD,a Rochester, MinnEmergency aortic valve replacement in the setting of
severe aortic valve stenosis and cardiogenic shock carries
increased risk of morbidity, including postcardiotomy
cardiac failure.1 Mechanical circulatory support with
extracorporeal membrane oxygenation (ECMO) can be a
lifesaving therapy for such patients. We report here the
management of a patient with severe prosthetic aortic
stenosis in cardiogenic shock whom we treated with
ECMO therapy to achieve clinical stabilization before
urgent aortic valve replacement.CLINICAL SUMMARY
A 77-year old woman was admitted with a non–ST-
segment myocardial infarction, severe prosthetic aortic
valve stenosis, and an ejection fraction of 37%. The patient
had cardiogenic shock develop and underwent placement of
an intra-aortic balloon pump. This resulted in stabilization
of her systemic blood pressure; however, acute kidney
injury developed, with low urinary output (67 mL over
6 hours) and elevated serum creatinine level (acute increase
from 1.6 to 2.2 mg/dL).
The patient was taken to the operating room for emergency
reoperative aortic valve replacement. On induction of anes-
thesia, systemic systolic arterial hypotension (83 mm Hg)
and pulmonary systolic arterial hypertension (71 mm Hg)
developed. The patient required frequent intravenous boluses
of epinephrine to maintain perfusion, and we did not believe
that she would survive long enough to allow the planned re-
operative aortic valve replacement.
We decided to proceed with ECMO therapy. Arterial
cannulation was performed with a 10-mm Gelsoft graft
(Terumo Cardiovascular Systems Corporation, Ann Arbor,
Mich) sutured as a chimney graft to the right axillary artery.
A Bio-Medicus venous cannula (Medtronic Bio-Medicus,
Inc, Eden Prairie, Minn) was placed through the right
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improvement, with normalization of the systemic systolic
arterial blood pressure (128 mm Hg), pulmonary systolic
arterial pressure (39 mm Hg), urinary output (3265 mL
over 24 hours), serum creatinine level (1.3 mg/dL), and
chest radiographic appearance (Figure 1, A and B).
The patient was returned to the operating room 36 hours
later to undergo reoperative aortic valve replacement. This
operation included institution of cardiopulmonary bypass
though the ECMO cannulas, resternotomy, myocardial
protection with antegrade and retrograde cardioplegia,
aortic root enlargement, and aortic valve replacement with
a 21-mm Carpentier Edwards Perimount valve (Edwards
Lifesciences, Irvine, Calif). The patient was separated
from cardiopulmonary bypass without difficulty.
The postoperative course was marked by continuous
improvement. The intra-aortic balloon pump was removed
on postoperative day 2, and the patient was extubated on
day 4. Renal function remained stable (creatinine level,
1.5 mg/dL). Discharge echocardiography showed a
normally functioning prosthetic aortic valve. The patient
was discharged home on day 13 with New York Heart
Association class I function (Figure 1, C).DISCUSSION
Clinical management of severe prosthetic aortic valve
stenosis with cardiogenic shock poses a formidable chal-
lenge. Emergency operative intervention in this setting is
associated with an increased risk of mortality, as noted by
O’Brien and colleagues,2 who reported a mortality odds ra-
tio of 3.77 (95% confidence interval, 2.75–5.16) in this
group of patients.
Preoperative ECMO therapy in our patient resulted in
restoration of cardiac output with improvement in organ
function. Other treatment options included proceeding with
a balloon aortic valvuloplasty or transcatheter aortic valve
replacement.3,4 We decided against these because of (1)
potential acute aortic regurgitation as the result of rupture
of a bioprosthetic valve cusp, (2) nonapproved transcatheter
technique, and (3) clinical improvementwith ECMOtherapy.
The role of preoperative ECMO therapy in patients such
as ours is not well established. Larger studies are needed
to define the role of ECMO therapy in acutely sick
patients with aortic valve disease. The idiom, ‘‘an ounce
of prevention is worth a pound of cure,’’ may have applica-
tion to this group of patients.gery c March 2014
FIGURE 1. A, Chest radiograph after extracorporeal membrane oxygenation institution. B, Resolving pulmonary edema on extracorporeal membrane
oxygenation support can be seen on the chest radiograph before aortic valve replacement. C, Chest radiograph before discharge from the hospital.
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Implication for aortic root reimplantationLiam P. Ryan, MD,a Melissa M. Levack, MD,b Joseph H. Gorman III, MD,b Robert C. Gorman, MD,b
Rita C. Milewski, MD, PhD,c and Joseph E. Bavaria, MD,c Charlotte, NC, and Philadelphia, PaThe aortic valve reimplantation technique described and
popularized by David and associates1 has demonstrated
consistently excellent long-term outcomes during the past
2 decades in patients with aortic root dilatation but structur-
ally normal, trileaflet aortic valves. The success of this oper-
ation, originally conceived as an alternative to aortic root
replacement in patients with Marfan syndrome, has encour-
aged the broader application of derivative techniques to a
number of distinct clinical scenarios, including bicuspidaortic valve (BAV) syndrome with root dilatation and aortic
insufficiency.2 Transposition of these valve-sparing tech-
niques, all of which depend on restoration of functionally
normal annular and leaflet geometry, to this geometrically
unique patient population requires a thorough understanding
of normal 3-dimensional BAV root complex geometry.3 To
date, our collectiveunderstandingof root geometry in this pa-
tient population has largely been limited to 2-dimensional
and anecdotal descriptors,which varymarkedly among clini-
cians and institutions.4,5 In this study, we describe the
rotational orientation of the aortic valve commissures in a
cohort of patients with BAV without evidence of adverse
remodeling. Our findings, which describe BAV root
asymmetry in quantitative terms for the first time, have
substantial implications for the ongoing evolution of valve-
sparing operative techniques in this patient population.MATERIALS AND METHODS
Real time 3-dimensional echocardiographic data sets were acquired on
8 normal patients (tricuspid n ¼ 4 and BAV n ¼ 4) with an iE-33 platform
(Philips Medical Systems, Andover, Mass) equipped with a 2- to 7-MHz
X7-2t transesophageal echocardiography matrix-array transducer. Inclu-
sion criteria for both groups comprised maximum root diameter less thandiovascular Surgery c Volume 147, Number 3 1103
